Irinotecan Hydrochloride Trihydrate Pharmaceutical Raw Drug

» Pharmaceutique » Les médicaments anti-tumeur » Irinotecan Hydrochloride Trihydrate Pharmaceutical Raw Drug

  • Caractéristiques

Buy Irinotecan Hydrochloride Trihydrate Pharmaceutical Raw Anti-tumor Drugs Online

 

Irinotecan Hydrochloride Trihydrate Specification

Nom du produit: Irinotecan Hydrochloride Trihydrate
NO CAS: 136572-09-3
Level: Pharmaceutical grade
Content: 99%
Apparence: white powder
Number of meshes:80 mesh
Emballage: 500G/aluminum foil bag
Category: Plant Extracts
Field: Pharmaceuticals
Deferred products: irinotecan hydrochloride tablets; irinotecan hydrochloride injection
Use: For patients with advanced colorectal cancer, combined with 5-fluorouracil and folinic acid in patients with advanced colorectal cancer who have not received chemotherapy before, as a single medication, to treat patients who failed treatment with 5-fluorouracil chemotherapy
Usage and dosage: 1 A method for small cell lung cancer and non-small cell lung cancer, B method for cervical cancer and ovarian cancer. A method: adult 100mg/m2, intravenous drip, 1 week interval and then repeat the intravenous infusion, 3 à 4 times for a course of treatment. At least two weeks before the next course of treatment. Need to repeat a few courses. B method: 150 mg/m2, 1 intravenous drip, withdrawal for 2 weeks. Repeat 2 or 3 times in this way as a course of treatment, at least 3 weeks before stopping treatment for the next course of treatment. This method can be repeated. The dose may be appropriately increased or decreased according to age, weight, and condition. 2 When this product is used, it needs to be mixed with more than 500ml of physiological saline, glucose solution or electrolyte infusion agent, and then slowly instill for more than 90 minutes.

 

Irinotecan Hydrochloride Trihydrate Certificate of Analysis

Nom du produit Irinotecan Hydrochloride Trihydrate
CAS No. 100286-90-6 Emballage externe 25kg / tambour
Date de production Sep, 28, 2017 Durée de conservation Sep, 27, 2019
Norme adoptée Standard de l’entreprise
Éléments d’analyse Spécification du Résultats
ASSAY (on dried basis) 98.0%–102.0% 99.8%
CHARACTERS Light yellow or almost yellow,crystalline powder and odorless. Conformes
IDENTIFICATION Infrared Absorption:In accordance with the reference Standard spectrum of Irinotecan Hydrochloride. Conformes
RESIDUE ON IGNITION NMT 0.1 % 0.07 %
HEAVY METALS NMT 0.001 % <0.001%
WATER(K.F) 7.0 %—9.0 % 8.3 %
RELATED COMPOUNDS (HPLC) (on dried basis) 11-Ethyl irinotecanc≤0.15%

7,11-Diethyl-10-hydroxycamptothecing≤0.15%

Undetected

Undetected

Conclusion Qualifié

 

Sales Contacts

Tel/Whatsapp: +86 17707567122
Wickr: mollyying
Télégramme: +86 185785209851
Skype: ying_2073
Mail: ying@wumeitech.com

formulaire ( nous reviendrons dès que possible )

prénom:
*
Email:
*
Message:

Vérification:
2 + 5 = ?

Peut-être que vous aimez aussi

  • catégories de produits

  • Messages récents

  • Partager